Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). RESULTS: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). CONCLUSIONS: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended (Fig. 10.5), in part because these high-risk people should already be receiving intensive medical therapy-an approach that provides benefits similar to those of invasive revascularization (208,209).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [208]
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended, in part because these high-risk people should already be receiving intensive medical therapy—an approach that provides benefits similar to those of invasive revascularization (197,198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [197]
In the citing paper
“OMT with risk modification remains the foundation of management in patients with T2DM and CAD.263,264”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [264]
In the citing paper
“these high-risk patients should already be receiving intensive medical therapy -an approach that provides benefi t similar to invasive revascularization (172,173).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [172]
In the citing paper
“The screening of asymptomatic patients remains controversial, especially as intensive medical therapy indicated in diabetic patients at high risk for CVD has an increasing evidence base for providing equal outcomes to invasive revascularization, including in diabetic patients (222).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [222]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
Cited by
Items 601–700 of 1,002
Turan, T. N., Lynn, M., Nizam, A., Lane, B. F., Egan, B. M., Le, N., Lopes-Virella, M. F., Hermayer, K. L., Benavente, O., White, C. L., et al. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966911 · Cited by 55
Miura, T., Soga, Y., Doijiri, T., Aihara, H., Yokoi, H., Iwabuchi, M., & Nobuyoshi, M. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0535 · Cited by 60
Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes
Boddi, M., Tarquini, R., Chiostri, M., Marra, F., Valente, S., Giglioli, C., Gensini, G. F., & Abbate, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12065 · Cited by 55
Murphy, A., Mahal, A., Richardson, E., & Moran, A. E. (2013) · International Journal for Equity in Health · doi:10.1186/1475-9276-12-38 · Cited by 54
“This is particularly worrisome given the importance of adherence to a standard daily drug regimen as a means of reducing the likelihood of acute coronary event [41].”
BackgroundTektonidou, M. G., Wang, Z., & Ward, M. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39758 · Cited by 56
“These decreases may reflect improvements in the care of patients with CVD or stable angina (16), but the significance of any improvements is unclear in light of increases in the rates of acute MI.”
BackgroundBaptista, S. B., Raposo, L., Santos, L., Ramos, R. B., Calé, R., Jorge, E., Machado, C., Costa, M., de Oliveira, E. I., Costa, J., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.115.003288 · Cited by 54
CT Myocardial Perfusion Imaging: A New Frontier in Cardiac Imaging
Seitun, S., Lorenzi, C. D., Cademartiri, F., Buscaglia, A., Travaglio, N., Balbi, M., & Bezante, G. P. (2018) · BioMed Research International · doi:10.1155/2018/7295460 · Cited by 56
O’Fee, K., Deych, E., Ciani, O., & Brown, D. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.5726 · Cited by 59
Dimeling, G., Bakaeen, L., Khatri, J. J., & Bakaeen, F. G. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20115 · Cited by 68
“14,15 Comparisons of CABG and medical therapy are dated, and emphasis now is on complementary rather than competing therapies.”
BackgroundModulation of myocardial metabolism: an emerging therapeutic principle
Horowitz, J. D., Chirkov, Y. Y., Kennedy, J. A., & Sverdlov, A. L. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328339f191 · Cited by 60
Blankenship, J. C., Gigliotti, O. S., Feldman, D. N., Mixon, T. A., Patel, R. A. G., Sorajja, P., Yakubov, S. J., & Chambers, C. E. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24701 · Cited by 53
Acute myocardial infarction and underlying stenosis severity
Fröbert, O., Veer, M. V. ’., Aarnoudse, W., Simonsen, U., Koolen, J., & Pijls, N. H. J. (2007) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21280 · Cited by 57
Kim, L. K., Feldman, D. N., Swaminathan, R. V., Minutello, R. M., Chanin, J. M., Yang, D. C.-S., Lee, M. K., Charitakis, K., Shah, A. M., Kaple, R., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.013 · Cited by 53
Technical challenges of coronary CT angiography: Today and tomorrow
Hassan, A., Nazir, S. A., & Alkadhi, H. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.02.011 · Cited by 52
Cardiovascular Disease in the Elderly
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.05.003 · Cited by 78
Mancini, G. B. J., Hartigan, P. M., Bates, E., Sedlis, S. P., Maron, D. J., Spertus, J. A., Berman, D. S., Kostuk, W. J., Shaw, L. J., Weintraub, W. S., et al. (2011) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.110.960062 · Cited by 53
Self-citationCortigiani, L., Rigo, F., Gherardi, S., Galderisi, M., Bovenzi, F., Picano, E., & Sicari, R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.08.011 · Cited by 53
The Role of Individual and Organizational Expertise in the Adoption of New Practices
Greenwood, B. N., Agarwal, R., Agarwal, R., & Gopal, A. (2018) · Organization Science · doi:10.1287/orsc.2018.1246 · Cited by 64
Faroux, L., Campelo‐Parada, F., Muñoz-García, É., y, L. N.-F., Fischer, Q., Donaint, P., Serra, V., Fernández, G. V., Gutiérrez, E., Vilalta, V., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.07.009 · Cited by 59
Matsuo, S., Nakajima, K., Horie, M., Nakae, I., Nishimura, T., & The J-ACCESS Investigators (2007) · Circulation Journal · doi:10.1253/circj.72.611 · Cited by 53
Hu, G., Oboukhova, E., Kumar, S., Sturek, M. S., & Obukhov, A. G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0350 · Cited by 56
Woodward, W. J., Dockerill, C., McCourt, A., Upton, R., O’Driscoll, J. M., Balkhausen, K., Chandrasekaran, B., Firoozan, S., Kardos, A., Wong, K., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab092 · Cited by 65
Vascular (dys)function in the failing heart
Liberale, L., Duncker, D. J., Hausenloy, D. J., Kraler, S. C., Bøtker, H. E., Podesser, B. K., Heusch, G., & Kleinbongard, P. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01163-w · Cited by 61
“In the COURAGE trial 230 , PCI of one coronary vessel did not reduce the risk of death, myocardial infarction or other major cardiovascular events when added to optimal medical therapy compared with optimal medical therapy alone at a median follow-up of 4.6 years.”
InfluentialFerguson, T. B., Chen, C., Babb, J. D., Efird, J. T., Daggubati, R. B., & Cahill, J. M. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.06.026 · Cited by 52
Shared Decision Making in Patients with Stable Coronary Artery Disease: PCI Choice
Coylewright, M. J., Shepel, K., LeBlanc, A., Pencille, L. J., Hess, E. P., Shah, N. D., Montori, V. M., & Ting, H. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049827 · Cited by 52
“These recommendations are in part based upon COURAGE, a large, randomized trial demonstrating no difference in rates of MI or death for PCI+OMT over OMT in stable angina [20].”
MethodBlankenship, J. C., Marshall, J. J., Pinto, D. S., Lange, R. A., Bates, E., Holper, E. M., Grines, C. L., & Chambers, C. E. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24376 · Cited by 64
Self-citationCoronary artery disease in 2010
Tardif, J. (2010) · European Heart Journal Supplements · doi:10.1093/eurheartj/suq014 · Cited by 71
“The results of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial, published in 2007, showed no benefit in terms of all-cause mortality, MI, or other major cardiovascular events of adding PCI in stable CAD patients receiving optimized medical therapy.(64) Moreover, the mar…”
ResultBen‐Yehuda, O., Kazi, D. S., Bonafede, M., Wade, S. W., Machacz, S. F., Stephens, L. A., Hlatky, M. A., & Hernandez, J. B. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26365 · Cited by 52
Benton, S. M., Tesche, C., Cecco, C. N. D., Duguay, T. M., Schoepf, U. J., & Bayer, R. R. (2017) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000289 · Cited by 57
Hochman, J. S., & Steg, P. G. (2007) · New England Journal of Medicine · doi:10.1056/nejme078036 · Cited by 53
Bansilal, S., Farkouh, M. E., Hueb, W. A., Ogdie, M., Dangas, G., Lansky, A. J., Cohen, D. J., Magnuson, E. A., Ramanathan, K., Tanguay, J., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.06.012 · Cited by 51
Inohara, T., Kohsaka, S., Miyata, H., Ueda, I., Ishikawa, S., Ohki, T., Nishi, Y., Hayashida, K., Maekawa, Y., Kawamura, A., et al. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.06.006 · Cited by 51
Bertoméu, V., Cordero, A., Quiles, J., Mazón, P., Aznar, J., & Bueno, H. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)71694-x · Cited by 58
Ohyama, K., Matsumoto, Y., Amamizu, H., Uzuka, H., Nishimiya, K., Morosawa, S., Hirano, M., Watabe, H., Funaki, Y., Miyata, S., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309843 · Cited by 51
Dai, N., Che, W., Liu, L., Zhang, W., Yin, G., Xu, B., Xu, Y., Duan, S., Yu, H., Li, C., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.735743 · Cited by 54
“However, post-PCI angina and/or ischemia may recur or persist in a significant patient subset (16), with reported rates ranging from 15% to more than 50% (17, 18).”
BackgroundClinical Updates in Coronary Artery Disease: A Comprehensive Review
Bottardi, A., Prado, G. F. A., Lunardi, M., Fezzi, S., Pesarini, G., Tavella, D., Scarsini, R., & Ribichini, F. L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164600 · Cited by 68
“In both groups, there was a consistent reduction in the relief of angina during follow-up despite significantly lower values in the PCI group at 1 year ( p 0.001) and at 3 years ( p = 0.02), while at 5-year follow-up, the differences between the two groups disappeared ( p = 0.35) [93,94].”
ResultInfluentialNallamothu, B. K., Tommaso, C. L., Anderson, H. V., Anderson, J. L., Cleveland, J. C., Dudley, R. A., Duffy, P. L., Faxon, D. P., Gurm, H. S., Hamilton, L. A., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441966.31451.3f · Cited by 51
Complementary Therapy Systems and Their Integrative Evaluation
Kienle, G. S., Albonico, H. U., Fischer, L., Frei-Erb, M., Hamre, H. J., Heusser, P., Matthiessen, P. F., Renfer, A., & Kiene, H. (2011) · EXPLORE · doi:10.1016/j.explore.2011.02.001 · Cited by 55
Kureshi, F., Jones, P. G., Buchanan, D. M., Abdallah, M. S., & Spertus, J. A. (2014) · BMJ · doi:10.1136/bmj.g5309 · Cited by 52
Self-citationChou, R. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1225 · Cited by 57
Fowler, F. J., Gallagher, P. M., Bynum, J., Barry, M. J., Lucas, F. L., & Skinner, J. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2009-5 · Cited by 50
Five year prognosis in patients with angina identified in primary care: incident cohort study
Buckley, B. S., Simpson, C. R., McLernon, D. J., Murphy, A. W., & Hannaford, P. C. (2009) · BMJ · doi:10.1136/bmj.b3058 · Cited by 50
“It is interesting that in this incident cohort of people with a first diagnosis of angina derived from primary care, neither coronary artery bypass grafting nor percutaneous transluminal coronary angioplasty was associated with significantly improved survival. It must be borne in mind that the findings relating to the…”
BackgroundStudying Disability Trends in Aging Populations
Gu, D., Gómez-Redondo, R., & Dupre, M. E. (2014) · Journal of Cross-Cultural Gerontology · doi:10.1007/s10823-014-9245-6 · Cited by 57
“, myocardial infarction), its benefit is much less in stable patients; thus, the overall benefit of coronary stents has limited advantage in improvement of survival beyond the best medical treatment (Boden et al. 2007).”
BackgroundMotivala, A. A., Parikh, V. K., Roe, M. T., Dai, D. W. H., Abbott, J. D., Prasad, A., & Mukherjee, D. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.05.048 · Cited by 57
“Due to findings from COURAGE trial and other studies, b-blockers remain an essential ingredient of optimal medical therapy for patients with stable angina (3,8,9,21,32).”
ResultNelson, A. J., Ardissino, M., & Psaltis, P. J. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319884819 · Cited by 58
Miller, R. J. H., Bonow, R. O., Gransar, H., Park, R. H., Slomka, P. J., Friedman, J. D., Hayes, S. W., Thomson, L., Tamarappoo, B. K., Rozanski, A., et al. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa083 · Cited by 52
Self-citationDiamond, G. A., & Kaul, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.010 · Cited by 51
Lentine, K. L., Schnitzler, M. A., Brennan, D. C., Snyder, J. J., Hauptman, P. J., Abbott, K. C., Axelrod, D. A., Salvalaggio, P. R. D. O., & Kasiske, B. L. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05351107 · Cited by 49
“Two recent randomized trials failed to support benefit of revascularization over contemporary medical management in stable general population samples, including patients awaiting major vascular surgery (16,17).”
BackgroundOptimizing Management of Stable Angina
Montone, R. A., Rinaldi, R., Niccoli, G., Andò, G., Gragnano, F., Piccolo, R., Pelliccia, F., Moscarella, E., Zimarino, M., Fabris, E., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.015 · Cited by 55
Revascularization in Severe Left Ventricular Dysfunction
Velazquez, E. J., & Bonow, R. O. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.070 · Cited by 49
Javadzadegan, A., Yong, A. S. C., Chang, M., Ng, A. C. C., Yiannikas, J., Ng, M., Behnia, M., & Kritharides, L. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00428.2012 · Cited by 53
Population Trends in Rates of Coronary Revascularization
Yeh, R. W., Mauri, L., Wolf, R. E., Romm, I. K., Lovett, A., Shahian, D., & Normand, S.-L. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7129 · Cited by 48
Yang, J. H., Kim, B. S., Jang, W. J., Ahn, J., Park, T. K., Song, Y. B., Hahn, J., Choi, J., Lee, S. H., Gwon, H., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0673 · Cited by 49
Taqueti, V. R., & Carli, M. F. D. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000339 · Cited by 51
“Recent randomized trials [10,11] did not show an event-free survival benefit for the addition of coronary revascularization to guidelinedirected medical therapy (GDMT), whereas an approach using fractional flow reserve (FFR)-guided revascularization [12] to identify lesion-specific ischemia was beneficial.”
BackgroundPazhenkottil, A. P., Benz, D. C., Gräni, C., Madsen, M. A., Mikulicic, F., von Felten, E., Fuchs, T. A., Moch, B. H., Stehli, J., Lüscher, T. F., et al. (2018) · Radiology · doi:10.1148/radiol.2018171303 · Cited by 55
Baumann, A. A. W., Mishra, A., Worthley, M. I., Nelson, A. J., & Psaltis, P. J. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320938527 · Cited by 61
How stiffening of the aorta and elastic arteries leads to compromised coronary flow
OʼRourke, M. F. (2008) · Heart · doi:10.1136/hrt.2007.134791 · Cited by 50
“approaches that can be directed at its relief.(2)”
BackgroundKleiman, N. S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.019 · Cited by 49
Advances in the Understanding of Plaque Composition and Treatment Options
Tomey, M. I., Narula, J., & Kovacic, J. C. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.042 · Cited by 56
“In the last decade, this shift was punctuated by results of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial in which an initial strategy of local therapy (revascularization) conferred no advantage for prevention of the composite of death or nonfatal MI above and beyond…”
ResultLate Clinical Events After Drug-Eluting Stents
Leon, M. B., Allocco, D. J., Dawkins, K. D., & Baim, D. S. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.04.004 · Cited by 51
“The annual rates of death observed in this study beyond 1 year are similar to those reported by Cutlip et al. (11) in their pooled BMS analysis and those reported in coronary artery disease patients treated with medical therapy alone (17–23), including studies of primary prevention (24–28).”
ResultIs Health Spending Excessive? If So, What Can We Do About It?
Aaron, H. J., & Ginsburg, P. Β. (2009) · Health Affairs · doi:10.1377/hlthaff.28.5.1260 · Cited by 48
Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction
Camici, P. G., Gloekler, S., Levy, B. I., Skalidis, E. I., Tagliamonte, E., Vardas, P. E., & Heusch, G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.001 · Cited by 47
“In the COURAGE trial more than 25% of patients were still experiencing angina 1 year after PCI, and at 5-year follow-up the incidence of angina was not significantly different from that in patients who did not undergo a revascularization procedure [5].”
MethodAkasaka, T., Sueta, D., Tabata, N., Takashio, S., Yamamoto, E., Izumiya, Y., Tsujita, K., Kojima, S., Kaikita, K., Matsui, K., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004841 · Cited by 52
“Moreover, reports from prior studies have noted that 50% of myocardial infarctions originate from changes in an existing pathology where treatment with a stent was deemed unnecessary.(36)”
ResultCardiovascular Disease in Diabetes
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc10-zb04 · Cited by 56
Bhatt, D. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.002 · Cited by 48
Patient-reported outcome measures in cardiovascular disease
Kornowski, R. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcab051 · Cited by 55
A Practical Approach to Left Main Coronary Artery Disease
Davidson, L. J., Cleveland, J. C., Welt, F. G. P., Anwaruddin, S., Bonow, R. O., Firstenberg, M. S., Gaudino, M. F. L., Gersh, B. J., Grubb, K. J., Kirtane, A. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.09.034 · Cited by 54
Impact of Complete Revascularization in the ISCHEMIA Trial
Stone, G. W., Ali, Z. A., O’Brien, S. M., Rhodes, G. L., Généreux, P., Bangalore, S., Mavromatis, K., Horst, J. A., Dressler, O., Poh, K. K., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.06.015 · Cited by 47
Self-citationJoshi, N. V., Vesey, A. T., Newby, D. E., & Dweck, M. R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0521-4 · Cited by 47
Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?
Vriese, A. S. D., Vandecasteele, S. J., Bergh, B. V. D., & Geeter, F. D. (2011) · Kidney International · doi:10.1038/ki.2011.340 · Cited by 47
“In the general population, however, coronary intervention does not improve survival in asymptomatic patients.(70,71) In non-renal patients, most myocardial infarctions result from erosion or rupture of unstable atherosclerotic plaques in coronary arteries that were not necessarily significantly narrowed (referred as T…”
BackgroundDesai, R. R., & Jha, S. K. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.10002 · Cited by 47
Ahmadi, A. A., Stone, G. W., Leipsic, J. A., Shaw, L. J., Villines, T. C., Kern, M. J., Hecht, H. S., Erlinge, D., Ben‐Yehuda, O., Maehara, A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308952 · Cited by 55
“CAD trials may, in part, explain why revascularization did not improve prognosis.(4,5,38) Moreover, patients were enrolled”
BackgroundSelf-citationFeres, F., Ra, C., Siqueira, D., Costa, J., Jr., Chamié, D., Staico, R., Aj, C., Abizaid, A., Marin‐Neto, J. A., Rassi, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170111 · Cited by 58
Mordi, I. R., Badar, A., Irving, R., Weir-McCall, J. R., Houston, J. G., & Lang, C. C. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s106838 · Cited by 52
“The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial demonstrated that although percutaneous coronary intervention (PCI) in addition to optimal medical therapy (OMT) reduced frequency of angina compared to OMT alone, there was no reduction in death, nonfatal myocardial infar…”
MethodYang, X., He, K., Pan, C., Li, Q., Liu, Y., Yan, L., Wei, X., Hu, B., Chang, X., Mao, X.-W., et al. (2015) · Scientific Reports · doi:10.1038/srep10739 · Cited by 50
Uebleis, C., Becker, A., Griesshammer, I., Cumming, P. D., Becker, C. R., Schmidt, M., Bartenstein, P., & Hacker, M. (2009) · Radiology · doi:10.1148/radiol.2531082137 · Cited by 47
Alcock, R., Yong, A. S. C., Ng, A. C. C., Chow, V., Cheruvu, C., Aliprandi‐Costa, B., Lowe, H. C., Kritharides, L., & Brieger, D. B. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.04.011 · Cited by 51
CLINICAL UTILITY OF REGADENOSON FOR ASSESSING FRACTIONAL FLOW RESERVE
Nair, P. K., Khandhar, S., Gulati, V. K., Schindler, J. T., Marroquin, O. C., Mulukutla, S. R., & Lee, J. S. (2011) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(11)61849-4 · Cited by 46
Wimmer, N. J., Scirica, B. M., & Stone, P. H. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.07.001 · Cited by 47
Prasad, V. K., Cheung, M., & Cifu, A. S. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.4037 · Cited by 45
Yao, S., Bangalore, S., & Chaudhry, F. A. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.05.004 · Cited by 46
Maron, D. J., Spertus, J. A., Mancini, G. B. J., Hartigan, P. M., Sedlis, S. P., Bates, E., Kostuk, W. J., Dada, M. R., Berman, D. S., Shaw, L. J., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.056 · Cited by 46
“The present post hoc analyis resembled previous comparisons of routine versus selecive invasive strategies in patients with ACS,(14) but it was ifferent in 2 important respects: (1) all patients underwent ardiac catheterization at baseline, and (2) all patients had tabilized after their recent ACS and hence were at lo…”
MethodResultSelf-citationThe adequacy of myocardial revascularization in patients with multivessel coronary artery disease
Zimarino, M., Curzen, N. P., Cicchitti, V., & Caterina, R. D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.05.004 · Cited by 46
“The clinical implication of the reduction of ischemia is well documented in the Clinical Outcomes Utilizing Revascularization and AGgressive drug Evaluation (COURAGE) study [24], where PCI and optimal medical therapy (OMT) had apparently similar clinical outcomes in a large population of stable patients.”
MethodFokkema, M. L., James, S. K., Albertsson, P., Aasa, M., Åkerblom, A., Calais, F., Eriksson, P., Jensen, J., Scherstén, F., de Smet, B. J. G. L., et al. (2016) · EuroIntervention · doi:10.4244/eijy15m10_07 · Cited by 46
Management of Stable Angina – Current Guidelines: A Critical Appraisal
Thadani, U. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6681-2 · Cited by 48
Wang, E. Y., Dixson, J. A., Schiller, N. B., & Whooley, M. A. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.09.006 · Cited by 51
Zheng, Q.-N., Wei, X., Pan, C., Li, Q., Liu, Y., Fan, J., & Han, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104272 · Cited by 50
The Regulatory Role of T Cell Responses in Cardiac Remodeling Following Myocardial Infarction
Kino, T., Khan, M., & Mohsin, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145013 · Cited by 53
Kaul, S., Shah, P. K., & Diamond, G. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.030 · Cited by 46
Clinical Conundrum of Coronary Artery Disease and Aortic Valve Stenosis
Sabbagh, A. E., & Nishimura, R. A. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005593 · Cited by 46
Noninvasive Coronary Atherosclerotic Plaque Imaging
Kwieciński, J., Tzolos, E., Williams, M. C., Dey, D., Berman, D. S., Slomka, P. J., Newby, D. E., & Dweck, M. R. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.08.021 · Cited by 57
Self-citationPercutaneous coronary intervention and 30‐day mortality: The British Columbia PCI risk score
Hamburger, J., Walsh, S. J., Khurana, R., Ding, L., Gao, M., Humphries, K. H., Carere, R. G., Fung, A., Mildenberger, R. R., Simkus, G. J., et al. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22151 · Cited by 45
The role of radionuclide myocardial perfusion imaging for asymptomatic individuals
Hendel, R. C., Abbott, B., Bateman, T. M., Blankstein, R., Calnon, D. A., Leppo, J. A., Maddahi, J., Schumaecker, M. M., Shaw, L. J., Ward, R. P., et al. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-010-9320-5 · Cited by 45
“That is, there is no evidence that follow-up angiography and revascularization improved outcomes for the asymptomatic patient with ischemia, although it did result in improved angina stability and frequency when compared to optimal medical therapy alone.(17)”
MethodResultSelf-citationFröhlich, G., Redwood, S. R., Rakhit, R. D., MacCarthy, P. A., Lim, P. O., Crake, T., White, S. K., Knight, C. J., Kustosz, C. P., Knapp, G., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1595 · Cited by 53
In vivo assessment of intraplaque and endothelial fibrin in ApoE−/− mice by molecular MRI
Makowski, M. R., Forbes, S. C., Blume, U. A., Warley, A., Jansen, C. H. P., Schuster, A., Wiethoff, A. J., & Botnar, R. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.008 · Cited by 47
Strom, J. B., Wimmer, N. J., Wasfy, J. H., Kennedy, K. F., & Yeh, R. W. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.000884 · Cited by 45
KONES, R. J., & Rumana, U. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1271957 · Cited by 51
Clinical significance of chronic myocardial ischemia in coronary artery disease patients
Rezende, P. C., Ribas, F. F., Junior, C. V. S., & Hueb, W. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.02.85 · Cited by 45
Dweck, M. R., Maurovich‐Horvat, P., Leiner, T., Cosyns, B., Fayad, Z. A., Gijsen, F. J. H., der Heiden, K. V., Kooi, M. E., Maehara, A., Muller, J. E., et al. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa201 · Cited by 48
Appropriateness Criteria for Coronary Angiography in Angina: Reliability and Validity
Hemingway, H., Chen, R., Junghans, C., Timmis, A., Eldridge, S. M., Black, N. A., Shekelle, P., & Feder, G. S. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-4-200808190-00003 · Cited by 44
Metadata
- Authors
- Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J., & Weintraub, W. S.
- Affiliations
- VA Western New York Healthcare System (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1503-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160414137
- Cited by
- 4,699
- References
- 49
- Citations by year
- 2026: 111 · 2025: 142 · 2024: 150 · 2023: 166 · 2022: 197 · 2021: 255 · 2020: 282 · 2019: 202 · 2018: 227 · 2017: 211 · 2016: 276 · 2015: 263 · 2014: 295 · 2013: 309 · 2012: 322
- FWCI
- 315.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- optimal medical therapy, percutaneous coronary intervention, stable coronary artery disease, myocardial ischemia, cardiovascular events, myocardial infarction, mortality, lifestyle intervention, coronary artery disease
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angina Pectoris, Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Antihypertensive Agents, Combined Modality Therapy, Coronary Disease, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Risk Factors, Angioplasty, Balloon, Coronary, Proportional Hazards Models, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.